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2211-3355/© 2016 The Authors. Published by Elsevier Inca b s t r a c ta r t i c l e i n f oAvailable online 2 February 2016 To investigate U.S. women's intended care seeking for symptoms associated with ovarian cancer, data from the
2012 HealthStyles Fall survey of U.S. adults were examined. Analyses were limited to women with no history
of gynecologic cancer (N=1726). Logistic regressionmodels for intended care seeking within 2 weeks of symp-
tom onset were developed. Aminority of women recognized that unexplained pelvic or abdominal pain (29.9%),
unexplained bloating (18.1%), and feeling full after eating a small amount of food (10.1%) can indicate ovarian
cancer, and 31.1%mistakenly believed that the Papanicolaou (Pap) test screens for the disease. In themultivariate
regressionmodels, themost consistent, signiﬁcant predictors (p b 0.01) of intended care seekingwithin 2 weeks
of symptom onset were age (older women were more likely to seek care) and awareness that symptoms could
signal ovarian cancer. Care seeking in response to ovarian cancer symptoms may be delayed among younger
women and those who do not recognize the potential signiﬁcance of symptoms. Raising awareness of ovarian
cancer symptoms may promote early detection. However, educational efforts should emphasize that symptoms
associated with ovarian cancer may also result from benign conditions.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Keywords:
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Ovarian cancer causes more deaths in the United States than any
other cancer of the female reproductive system. Annually, more than
20,000 U.S. women are diagnosed with ovarian cancer and more than
14,000 die from the disease (U.S. Cancer Statistics Working Group,
2014). Treatment is most effective when ovarian cancer is found at an
early stage. However, no population-based screening test is recom-
mended for ovarian cancer detection, and most ovarian cancers are
diagnosed at a late stage (Su et al., 2013).
While ovarian cancer has been widely referred to as a “silent killer,”
symptoms commonly associated with the disease have been identiﬁed
(Goff, 2012). Unfortunately, awareness of ovarian cancer symptoms
among U.S. women is low (Trivers et al., 2011; Cooper et al., 2013;
Lockwood-Rayermann et al., 2009). In addition, the misconception
that the Papanicolaou (Pap) test detects ovarian cancer is common
(Lockwood-Rayermann et al., 2009; Hawkins et al., 2011; Cooper
et al., 2011), and has been found to engender a false sense of security
in some women (Cooper et al., 2011). Given the absence of a
population-based screening test for ovarian cancer, early detection can
depend on women reporting symptoms to health care providers (Suon and Control, National Center
enters for Disease Control and
, GA 30341, USA. Fax: +1 770
. This is an open access article underet al., 2013; Goff et al., 2000). The present study investigated U.S.
women's intended care seeking for symptoms associated with ovarian
cancer.
Methods
TheHealthStyles Fall survey is an annual survey conducted by Porter
Novelli (Washington, D.C.) that explores the health behaviors and atti-
tudes of U.S. adults. The 2012HealthStyles Fall surveywas administered
online from September 21–October 5. The survey items analyzed here
were licensed by the Centers for Disease Control and Prevention's Inside
Knowledge:Get the Facts about Gynecologic Cancer campaign (Centers for
Disease Control and Prevention, 2015), to inform the campaign's initia-
tives to increase women's understanding of gynecologic cancer.
Participants
Participants in the 2012HealthStyles Fall surveywere recruited from
the KnowledgePanel®, a 50,000 member online research panel that is
representative of the U.S. population (GFK Knowledge Networks,
2015). Panel members were randomly recruited through probability-
based sampling, using both random-digit dial and address-based sam-
pling methods. If needed, panel members were provided with a laptop
computer and Internet access so they could take part in surveys.
The 2012 HealthStyles Fall survey was sent to a random sample of
4371 panel members aged 18 years or older who responded to anthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Table 1
Participant characteristics, ovarian cancer symptom awareness, awareness that
Papanicolaou (Pap) test does not screen for ovarian cancer, and timing of intended care
seeking for symptoms, U.S. Women, 2012 HealthStyles Fall Survey (N= 1726).
Unweighted
na
Weighted
%b
Participant characteristics
Age (years) 18–29 years 277 18.6
30–44 years 375 27.3
45–59 years 524 26.9
≥60 years 550 27.2
Race/ethnicity Caucasian 1272 65.0
African-American 188 13.0
Hispanic 172 15.2
Other 94 6.9
Educational attainment bHigh school 91 10.7
High school 496 33.7
Some college 545 28.8
≥Bachelor degree 594 26.8
Geographic region Northeast 336 18.8
Midwest 434 22.2
West 369 22.1
South 587 36.9
Health insurance coverage Insured 1450 81.2
Uninsured 266 18.8
Awareness that Pap does not screen for ovarian cancer
Aware 1204 68.9
Unaware 506 31.1
Awareness that symptom could signal ovarian cancer
Unexplained pelvic or
abdominal pain
Aware 575 29.9
Unaware 1105 70.1
Unexplained bloating Aware 363 18.1
Unaware 1317 81.9
Feeling full after eating a
small amount of food
Aware 183 10.1
Unaware 1497 89.9
Timing of intended care seeking for symptoms
Unexplained pelvic or
abdominal pain
Within a few days 558 32.9
Within 1–2 weeks 602 32.8
Within several weeks 304 19.2
After several months 100 6.7
I would probably not call
or see a doctor
115 8.4
Unexplained bloating Within a few days 189 10.8
Within 1–2 weeks 462 26.9
Within several weeks 456 25.0
After several months 183 12.0
I would probably not call
or see a doctor
380 25.4
Feeling full after eating a
small amount of food
Within a few days 120 7.0
Within 1–2 weeks 382 21.2
Within several weeks 441 25.7
After several months 197 13.2
I would probably not call
or see a doctor
537 32.8
a Analyseswere limited towomenwho had never been diagnosedwith gynecologic cancer.
When variable responses do not sum to N, responses are missing unless otherwise noted.
b Data were weighted to match 2012 U.S. Census estimates for age, household income,
race/ethnicity, educational attainment, and geographic region.
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participants (1733 men and 1770 women) took part in the survey,
for a completion rate of 80.1%. However, the analyses reported here
were limited to women with no history of gynecologic cancer
(N = 1726).
The 2012 HealthStyles Fall survey was administered by Porter
Novelli and complied with the ICC/ESOMAR International Code for eth-
ical research (Esomar, 2008). To protect participant conﬁdentiality, no
individual identiﬁers were included in the dataset received by investi-
gators. CDC Institutional Review Board (IRB) approval was not required
for this project because CDC licensed the 2012 HealthStyles data ana-
lyzed from Porter Novelli and was not engaged in human subjects
research (secondary data analysis).
Measures
Ovarian cancer symptom awareness was assessed by asking respon-
dents, “Which of the following could be awarning sign of ovarian cancer?”
The response options included three symptoms that are commonly associ-
ated with ovarian cancer (Goff, 2012): “unexplained pelvic or abdominal
pain,” “unexplained bloating,” and “feeling full after eating a small amount
of food,” aswell as eight other symptoms (e.g. “vaginal itching that doesnot
get betterwith over-the-counter treatments/creams”), “none of these,” and
“not sure.”Multiple responses to this item were accepted unless “none of
these” or “not sure”was selected.
Timing of intended care seeking in response to symptoms was
assessed by asking respondents, “If you began experiencing any of
the following and it was not normal for you, whenwould you contact
a doctor or other health professional?” Respondents were asked to
provide a separate response for each of the symptoms included in
the ovarian cancer symptom awareness item; ﬁve response options
were provided: “within a few days,” “within 1–2 weeks,” “within
several weeks,” “after several months,” and “I would probably not
call or see a doctor.”
Analyses
Investigators calculated weighted proportions (matched to 2012
U.S. estimates on gender, age, household income, race/ethnicity, educa-
tional attainment, and geographic region) for demographic characteris-
tics, ovarian cancer symptom awareness, and timing of intended care
seeking in response to symptoms. Pearson chi-square tests were used
to compare timing of intended care seeking for each of the three ovarian
cancer symptoms studied by participant characteristics and awareness
that each symptom could signal ovarian cancer. In this analysis, the re-
sponse categories for timing of intended care seeking were collapsed
into “≤2 weeks” (which included “within a few days” and “within 1–
2 weeks”), “N2 weeks” (which included “within several weeks,” “after
several months,” and “I would probably not call or see a doctor”). The
covariates found to be signiﬁcant (p b 0.05) in the bivariate analyses
were included in adjusted, forward-stepwise logistic regressionmodels
to predict intended care seeking within 2 weeks of symptom onset for
each of the three symptoms analyzed.
Results
A minority of women (10.1%–29.9%) recognized the symptoms that
could signal ovarian cancer, and 31.1% mistakenly believed that the Pap
test screens for ovarian cancer (Table 1).
Intended care seeking for symptoms within 2 weeks of their onset
ranged from 28.2% (feeling full after eating a small amount of food) to
65.7% (unexplained pelvic or abdominal pain). No intended care seek-
ing for symptoms ranged from 8.4% (unexplained pelvic or abdominal
pain) to 32.8% (feeling full after eating a small amount of food).
Covariates signiﬁcantly associated with intended care seeking with-
in 2 weeks of symptom onset in the bivariate analyses (SupplementalTable) were included in the adjusted logistic regression models: age,
race/ethnicity, educational attainment, geographic region, health insur-
ance coverage, and awareness that symptom can signal ovarian cancer.
Across the three symptoms modeled, intended care seeking within
2 weeks of symptom onset was most likely among women ≥60 years
old and those whowere aware that the symptom analyzed could signal
ovarian cancer (Table 2). Intended care seeking for unexplained
bloating and feeling full after eating a small amount within 2 weeks of
onset was more likely among African-American and Hispanic women
than Caucasian women and least likely among women living in the
Southern U.S. states. Finally, insured women were more than twice as
likely as uninsured women to report intended care seeking for unex-
plained pelvic or abdominal pain within 2 weeks of onset.
Table 2
Signiﬁcant predictors of intended care seeking for symptoms associated with ovarian cancer within 2 weeks, multivariate logistic regression, U.S. Women, 2012 HealthStyles Fall
Survey (N = 1726).
Model Symptom Signiﬁcant predictors of intended care seeking
Predictive
category
AOR 95% CI p-valuea
Reference
category
1 Unexplained pelvic or abdominal pain Age 18–29 years 0.53 0.38, 0.73 b0.001 ≥60 years
30–44 years 0.53 0.39, 0.71 b0.001
45–59 years 0.76 0.56, 1.03 0.074
Health insurance coverage Insured 2.17 1.67, 2.83 b0.001 Uninsured
Awareness that symptom can signal ovarian cancer Aware 1.41 1.11, 1.79 0.005 Unaware
2 Unexplained bloating Age 18–29 years 0.47 0.34, 0.64 b0.001 ≥60 years
30–44 years 0.47 0.36, 0.63 b0.001
45–59 years 0.62 0.47, 0.82 0.001
Race/ethnicity
African American 1.81 1.32, 2.47 b0.001
CaucasianHispanic 1.66 1.22, 2.26 b0.001
Other 1.09 0.71, 1.67 0.709
Region Northwest 1.53 1.15, 2.04 0.004 South
Midwest 1.01 0.76, 1.34 0.967
West 1.17 0.88, 1.56 0.274
Awareness that symptom can signal ovarian cancer Aware 1.72 1.32, 2.23 b0.001 Unaware
3 Feeling full after eating a small amount of food Age 18–29 years 0.36 0.25, 0.51 b0.001 ≥60 years
30–44 years 0.46 0.34, 0.62 b0.001
45–59 years 0.63 0.47, 0.83 0.001
Race/ethnicity
African American 1.89 1.37, 2.63 b0.001
CaucasianHispanic 1.51 1.09, 2.10 0.014
Other 0.78 0.47, 1.29 0.329
Region Northwest 1.65 1.21, 2.24 0.002 South
Midwest 1.55 1.14, 2.10 0.005
West 1.66 1.22, 2.26 0.001
Awareness that symptom can signal ovarian cancer Aware 1.70 1.21, 2.38 0.002 Unaware
Note: Forward-stepwise logistic regressionmodels included variables found to be signiﬁcant in bivariate analyses (Supplemental Table): age, race/ethnicity, geographic region, health in-
surance coverage, and awareness that symptom can signal ovarian cancer. Datawereweighted tomatch 2012 U.S. Census estimates for age, household income, race/ethnicity, educational
attainment, and geographic region. Analyses were limited to women who had never been diagnosed with gynecologic cancer.
a Boldface indicates statistical signiﬁcance (p b 0.05).
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Many women were not familiar with the ovarian cancer symptoms
included in the study. This knowledge deﬁcit consistently translated
into lower rates of intended care seeking within 2 weeks of symptom
onset, and this association persisted when demographic covariates
were controlled in logistic regression models.
Similarly, an analysis of UK women found low recognition of symp-
toms associated with ovarian cancer and variation in intention to seek
care for these symptoms (Low et al., 2013). Conversely, in a study of
Welsh women, ovarian cancer symptom awareness was not associated
with delayed care seeking; however, respondents' awareness of ovarian
cancer symptoms was much higher than in the current study (Brain
et al., 2014).
Age was also a signiﬁcant predictor of intended care seeking in the
present study, with older women being more likely to report intended
care seekingwithin twoweeksof symptomonset. Thisﬁnding is consistent
with prior research which examined anticipated care seeking in response
to symptoms associated with lung, colorectal, and breast cancer (Quaife
et al., 2014). The regional and racial/ethnic differences found in the present
study related to intended care seeking for unexplained bloating and feeling
full after eating a small amount of foodmay indicate cultural differences in
the interpretation of these symptoms or care seeking in general. Health in-
surance coverage was found to be a signiﬁcant predictor for intended care
seeking for only one of the symptoms studied—unexplained pelvic or ab-
dominal pain. However, the other symptoms analyzed were associated
with low rates of intended care seeking,whichmayhavemuted thepoten-
tial signiﬁcance of insurance coverage.
It should be noted that the present study did not include psycho-
logical covariates, such as embarrassment of symptom or fear of
cancer which were found to be major contributors to care seeking
delay in response to cancer symptoms in a systematic review of
this topic (Smith et al., 2005). Further, Walter et al.’s (2012))reﬁnement of the Anderson Model of Total Patient Delay to apply
the framework to cancer diagnosis recognizes the potential role of
psychological/social/cultural factors, co-morbidities, provider/
health system factors, and other variables not included in the present
study. In addition, the representativeness of women in the present
study may be limited by the use of a preassembled research panel.
While data were weighted to reﬂect the U.S. population, the extent
towhich results are generalizable is not known. In addition, the pres-
ent study investigated intended care seeking in a hypothetical con-
text, and women may respond differently in real life. Also, the data
are cross-sectional; thus, it is not possible to dissect how covariates
and intended care seeking are linked.
The ﬁve-year survival rate for late-stage ovarian cancer is approxi-
mately 30% (Su et al., 2013). Early detection leading to improved surviv-
al can begin with women reporting symptoms to health care providers.
Ongoing and effective efforts are needed to educate women about
ovarian cancer symptoms, when to seek care, and the lack of a
population-based screening test for ovarian cancer. At the same time,
care must be taken to explain to women that the symptoms associated
with ovarian cancer may also result from other conditions, many of
which are unrelated to cancer and relatively benign.
Early detection leading to improved survival can begin with women
reporting ovarian cancer symptoms to health care providers. Ongoing
and effective efforts are needed to educatewomen about ovarian cancer
symptoms, when to seek care, and the lack of a population-based
screening test for ovarian cancer.
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